FPCEE Blanquerna
Barcelona, 08022, Spain
NCT Number: NCT06747702
To evaluate and describe the effect of performing an integrated injury prevention exercises on the variables considered as injury risk factors in overhead athletes
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Barcelona, 08022, Spain
To evaluate and describe the effect of performing fast or 6-8 weeks injury prevention programs on the variables considered as injury risk factors in overhead athletes as glenohumeral rotational range of motion or muscle activation pattern and asymmetries.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The injury prevention workout consisted on engaging on a prevention program from 1 day to 8 weeks where the participants will develop functional sport exercises to prevent shoulder injuries or pain in overhead sports.
Time frame: From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks
Shoulder rotational range of movement will be measured made by a single experienced examiner with the IMU Output Capture (Output V2 Unit, Ireland). The IMU will be calibrated prior to ROM testing according to the device instructions. The IMU will be securely attached to the participant's forearm with a self-adhering strap, 10 cm distal to the lateral epicondyle. Measurements will be sent wirelessly to a tablet and subsequently transferred to the Output Hub specific software to calculate ROM
Time frame: From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks
Escapular complex muscular activation EMG recording will be measured with the mDurance® device (mDurance® Solutions SL, Granada, Spain). The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland). Muscles-activity data were obtained using a validated surface electromyography (EMG) system. This novel system includes a us-er-friendly software, and a light hardware, which make it more affordable and accessible for clinicians and sport trainers. The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland). The unit has a bipolar surface elec-tromyography bipolar sensor for the acquisition of muscle activity. Each Shimmer3 has two channels, with a sampling rate of 1024 Hz applying a bandwidth of 8.4 Hz, and a 24-bit signal with an overall amplification of 100 to10,000 v/v [41]. This device is valid and reliable for recording muscle activity during a functional task (ICC = 0.916; 95% CI = 0.831-0.958)
Time frame: From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks
Diferences in % the muscle activation of the interescapular muscle complex by EMG. These recording will be also performed with the mDurance® device (mDurance® Solutions SL, Granada, Spain). The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland) . This device is valid and reliable for recording muscle activity during a functional task (ICC = 0.916
Time frame: From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks
The Ability of recognizing a specific glenohumeral rotational range of movement degrees we will use the IMU Output Capture (Output V2 Unit, Ireland). The IMU was calibrated prior to ROM testing according to the device instructions. The IMU was securely attached to the participant's forearm with a self-adhering strap, 10 cm distal to the lateral epicondyle. Measurements were sent wirelessly to a tablet and subsequently transferred to the Output Hub specific software to calculate ROM
University Ramon Llull
Other
Effect of Integrated Workouts on Injury Prevention in Overhead Athletes
Acronym: IPOverhead
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details